Obituary: Barry Sherman

Apotex has paid its respects to the company’s founder and chairman, Barry Sherman, 75, and his wife Honey, 70, after they were found dead at their home in Toronto, Canada, on 15 December. The Canadian firm said it was with “profound sadness that we announce the unexpected passing” of Sherman, who founded privately-held Apotex in 1974. “From its humble two-employee, 5,000 square-feet beginning in Toronto, the company Dr Sherman founded grew into a global pharmaceutical organisation that today employs more than 11,000 people in research, development, manufacturing and distribution in facilities around the world,” Apotex commented.

Apotex has paid its respects to the company’s founder and chairman, Barry Sherman, 75, and his wife Honey, 70, after they were found dead at their home in Toronto, Canada, on 15 December. The Canadian firm said it was with “profound sadness that we announce the unexpected passing” of Sherman, who founded privately-held Apotex in 1974. “From its humble two-employee, 5,000 square-feet beginning in Toronto, the company Dr Sherman founded grew into a global pharmaceutical organisation that today employs more than 11,000 people in research, development, manufacturing and distribution in facilities around the world,” Apotex commented.

As news of the deaths broke, publications including the New York Post reported that investigators were treating the case as...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Archive

ADHD Medications and Cardiovascular Effects: New Data Revealed. (A Comprehensive Evaluation of Emerging Clinical and Epidemiological Evidence on the Cardiovascular Effects Associated with Prescribed Medications for Attention Deficit Hyperactivity Disorder) - Clone - Clone

 
• By 

A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.

Testing-Rising

 
• By 

Testing-Rising xxxx

bhvyuguig

lnkbkb

test 1

test 1

More from Generics Bulletin

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success - C9

 
• By 

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success - C8

 
• By 

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.

UK Invests £28m In NHS AI, But Industry Says Procurement And Training Will Determine Success - C7

 
• By 

The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.